ClinicalTrials.gg
RecruitingNCT07072091FocusVolleyUpdated Aug 14, 2025

Focusing the Shoulder or Considering the Whole-Body in Volleyball Physiotherapy

An interventional study of Total body physiotherapy and Focus shoulder physiotherapy in Shoulder Pain and Volleyball Players, sponsored by University of Trieste. Recruiting at 1 site in Italy. Open to participants aged 17 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-14.

Sponsored by University of Trieste · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Started Jul 2025; still recruiting 1 year 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
17 Years to 30 Years
Sex
All
01

Study summary

Shoulder pain can be common in overhead sports, and in particular, in volleyball. Different physiotherapy protocols can be adopted depending on the suspected pathophysiological mechanisms. Despite most of the protocols rely only on the shoulder district, some research suggests that treating the whole-body might produce better results as it could influence kinematic chains and correct muscle imbalances. The aim of this study will be to compare the effects of two physiotherapy protocols (shoulder focus or whole body) compared to only education without physiotherapy.

02

Conditions studied

  • Shoulder Pain
  • Volleyball Players

Browse trials for

03

In context

Shoulder Pain

735 studies on the registry are indexed under Shoulder Pain; 167 are open to participants now.

This study's planned enrollment of 40 is below the median of 60 across 587 interventional studies indexed under Shoulder Pain.

Browse Shoulder Pain studies →

Lead sponsor

University of Trieste is the lead sponsor of 39 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • practicing volleyball for at least 5 years with a training volume of minimum 5 h/wk

Exclusion criteria

Exclusion Criteria:

  • history of previous surgical intervention or fractures on the shoulder or spine
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • No intervention
    Healthy controls

    A convenience sample of healthy volleyball players for cross-sectional comparison

  • Experimental
    Total body physiotherapy group

    Physiotherapy intervention consisting in whole body exercise and treatment

    Other: Total body physiotherapy

  • Active comparator
    Focus shoulder group

    Physiotherapy intervention consisting in shoulder exercise and treatment

    Other: Focus shoulder physiotherapy

  • Other
    No physiotherapy group

    No physiotherapy, only education

    Other: Education

Interventions

  • OtherTotal body physiotherapy

    This intervention consists in 5 weeks of 2 x week 60 min sessions of physiotherapy consisting in active exercise performed in upper limb, trunk, and lower limb muscles, in a whole-body approach.

  • OtherFocus shoulder physiotherapy

    This intervention consists in 5 weeks of 2 x week 60 min sessions of physiotherapy consisting in active exercise performed only in the shoulder district, focusing on the trunk-arm muscles.

  • OtherEducation

    Single education session providing information about posture hygiene and proper warm-up

06

What researchers measure

Primary outcomes

  1. Isometric strength with handheld dynamometer (Newtons)

    Isometric strength during shoulder flexion, extension, external and internal rotation, bilaterally

    Time frame: At enrollment and at the end of treatment at 5 weeks

Secondary outcomes

  1. Lateral symmetry (%)

    Lateral symmetry will be assessed as percentage between the two upper limbs for the investigated muscles (pectoralis major, latissimus dorsi, upper trapezius, middle trepezius, lower trapezius, anterior deltoid, posterior deltoid) using the tensiomyography system

    Time frame: At enrollement and at the end of treatment after 5 weeks

  2. Time of contraction (ms)

    Time of contraction (ms), i.e. the time requiring the muscle to reach the peak of muscle displacement, will be assessed as percentage between the two upper limbs for the investigated muscles (pectoralis major, latissimus dorsi, upper trapezius, middle trepezius, lower trapezius, anterior deltoid, posterior deltoid) using the tensiomyography system

    Time frame: At enrollement and at the end of treatment after 5 weeks

  3. Muscle belly displacement (mm)

    Muscle belly displacement (mm), i.e. the amplitude of muscle displacement, will be assessed as percentage between the two upper limbs for the investigated muscles (pectoralis major, latissimus dorsi, upper trapezius, middle trepezius, lower trapezius, anterior deltoid, posterior deltoid) using the tensiomyography system

    Time frame: At enrollement and at the end of treatment after 5 weeks

07

Study locations

1 of 1 sites recruiting
  • University of Trieste - Exercise Physiology and Kinesiology Lab
    Trieste, Trieste 34100, Italy
    Recruiting
08

References and documents

Publications

  • Jones SD Jr, Safran MR. Current concepts: the hip, core and kinetic chain in the overhead athlete. J Shoulder Elbow Surg. 2024 Feb;33(2):450-456. doi: 10.1016/j.jse.2023.10.009. Epub 2023 Nov 23. PubMed 38007174 ↗
  • Erkan R, Telci EA. Impact of Stabilization Exercises on Athletic Performance and Injury Risk in College Volleyball Players. Int J Sports Physiol Perform. 2025 May 13;20(7):948-957. doi: 10.1123/ijspp.2024-0348. Print 2025 Jul 1. PubMed 40360147 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Sep 2025, 2 months after the start.

Of 349 non-industry interventional studies with no phase under Shoulder Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 27. This study's planned 2 months is below that.

Counting every sponsor, half of 354 studies reached it within 11 months; a quarter within 4 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
May 30, 2025
First posted
Jul 18, 2025
StartActual
Jul 20, 2025
Primary completionEst.
Sep 2025
CompletionEst.
Sep 2025
Last update
Aug 14, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07072091
Lead sponsor
University of Trieste
Responsible party
Alex Buoite Stella (PhD, Assistant professor, University of Trieste) — Principal investigator
First posted
Jul 18, 2025
Start date
Jul 20, 2025
Primary completion
Sep 2025 (estimated)
Completion
Sep 2025 (estimated)
Last update
Aug 14, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion